正子断层扫描（PET）市场规模、份额和成长分析（按产品、应用、最终用户和地区划分）—产业预测（2026-2033 年）

预计到 2024 年，正子断层扫描 (PET) 市场规模将达到 26.9 亿美元，到 2025 年将达到 28.6 亿美元，到 2033 年将达到 47.8 亿美元，在预测期（2026-2033 年）内，复合增长率为 6.61%。

癌症和阿兹海默症严重疾病的日益普及显着推动了正子断层扫描（PET）的需求成长。这些先进的成像技术能够提供人体生理和代谢活动的重要讯息，使其成为精准诊断和持续患者照护的关键工具。慢性病的增加正推动着治疗方案向标靶治疗和个人化医疗转变，而PET扫描在提供关键资讯以根据个别患者需求客製化治疗方案方面发挥着重要作用。此外，分子成像技术的进步以及人工智慧和机器学习的融合正在增强PET扫描的功能，提高成像的准确性和效率。因此，PET扫描在检查和临床诊断领域的应用不断扩展，从而推动了整体市场的成长。

正子断层扫描（PET）市场成长要素

癌症、阿兹海默症和心血管疾病等慢性病发病率的不断上升，显着推动了正子断层扫描（PET）市场的成长。这些复杂的疾病通常需要先进的成像技术进行精准诊断和后续观察。 PET检查在这一领域发挥关键作用，它能够提供重要的代谢和生理活动讯息，这些资讯对于制定有效的治疗策略和疾病管理至关重要。随着慢性病患者数量的持续成长，对PET扫描的需求也不断增加，这凸显了先进诊断技术在应对这些疾病管理挑战方面的必要性。

正子断层扫描（PET）市场限制

正子断层扫描（PET）市场面临的主要挑战之一是PET扫描仪的高昂成本。购买、营运和维护这些先进影像设备的费用构成了一大障碍，尤其对于预算有限的小规模医疗机构和诊断实验室而言更是如此。这些经济限制可能会阻碍资源匮乏地区获得PET扫描技术，并使其无法惠及真正需要的病患。因此，PET扫描仪的高昂价格有可能抑制市场成长，并限制这项创新成像技术在各个应用领域的拓展。

正子断层扫描（PET）市场趋势

由于人工智慧 (AI) 和机器学习技术的融合，正子断层扫描 (PET) 市场正经历着一场变革。这些技术的进步优化了影像撷取、重建和分析，提高了诊断的准确性和效率，增强了对细微异常的检测，并改善了肿瘤的特性。此外，机器学习工具能够预测患者预后并客製化治疗方案，进一步实现个人化患者照护。随着人工智慧和机器学习技术的不断发展，它们与 PET 系统的整合将彻底革新成像能力，进一步提升这项技术在临床和科学研究领域的价值。

目录

介绍

• 调查目标
• 定义
• 市场覆盖范围

调查方法

• 资讯收集
• 二手和一手资讯来源
• 市场规模预测
• 市场假设与限制

执行摘要

前景
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场动态
  • 司机
  • 机会
  • 抑制因素
  • 任务
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 价值链分析
• 供应链分析
• 专利分析
• 贸易分析
• 技术分析
• 监管环境
• 用例分析

正子断层扫描（PET）市场依产品分类

• 独立式PET系统
• PET/CT系统
  • 低切扫描仪
  • 中切扫描仪
  • 高切扫描器
• PET/MRI系统

按应用分類的正子断层扫描（PET）市场

• 肿瘤学应用
• 神经学应用
• 心血管应用
• 其他的

按最终用户分類的正子断层扫描（PET）市场

• 医院及手术中心
• 诊断和影像诊所
• 门诊治疗中心
• 其他的

正子断层扫描（PET）市场：按地区分類的市场规模

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • GCC
  • 南非
  • 其他中东和非洲地区

竞争格局

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市集活动
• 主要企业市占率（2025 年）

主要企业简介

• General Electric
• Koninklijke Philips NV
• Siemens AG
• Shanghai United Imaging Healthcare Co., Ltd
• Canon Inc.
• Shimadzu Corporation
• Mediso Ltd.
• MinFound Medical Systems Co., Ltd
• Neusoft Corporation
• Bruker
• CMR Naviscan
• Kindsway BioTech
• Hermes Medical Solutions
• Sofie Biosciences
• Prescient Medical Imaging
• Reflexion
• Cubresa Inc.
• Synchropet, Inc.
• Novartis
• Revvity Inc.

Positron Emission Tomography Market size was valued at USD 2.69 Billion in 2024 and is poised to grow from USD 2.86 Billion in 2025 to USD 4.78 Billion by 2033, growing at a CAGR of 6.61% during the forecast period (2026-2033).

The rising prevalence of critical diseases, including cancer and Alzheimer's, is significantly boosting the demand for Positron Emission Tomography (PET) scans. These advanced imaging technologies are essential for accurate diagnosis and ongoing patient care, as they provide crucial insights into the body's physiological and metabolic activities. The increasing burden of chronic illnesses is fostering a shift towards targeted therapeutics and personalized medicine, with PET scans playing a key role by delivering vital information that tailors treatments to individual patient needs. Furthermore, advancements in molecular imaging and the integration of AI and machine learning are enhancing PET scan capabilities, leading to improved imaging accuracy and efficiency. Consequently, the adoption of PET scans is expanding across research and clinical diagnostics, propelling growth in the overall market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Positron Emission Tomography market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Positron Emission Tomography Market Segments Analysis

Global Positron Emission Tomography Market is segmented by Product, Application, End User, and Region. Based on Product, the market is segmented into Standalone PET Systems, PET/CT Systems (Low-Slice Scanners, Medium-Slice Scanners, High-Slice Scanners), PET/MRI Systems. Based on Application, the market is segmented into Oncology Applications, Neurological Applications, Cardiovascular Applications, Other Applications. Based on End User, the market is segmented into Hospitals & Surgical Centers, Diagnostic & Imaging Clinics, Ambulatory Care Centers, Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Positron Emission Tomography Market

The rising incidence of chronic illnesses, including conditions like cancer, Alzheimer's, and cardiovascular diseases, significantly propels the growth of the Positron Emission Tomography (PET) market. These complex disorders often necessitate sophisticated imaging techniques for accurate diagnosis and ongoing evaluation. PET scans play a crucial role in this landscape by providing vital insights into metabolic and physiological activities, which are essential for effective treatment strategies and disease management. As the number of patients with chronic health issues continues to grow, the demand for PET scans intensifies, highlighting the need for advanced diagnostic technologies to navigate the challenges in managing these medical conditions.

Restraints in the Positron Emission Tomography Market

One of the significant challenges facing the Positron Emission Tomography market is the high expense associated with PET scanners. The costs incurred for purchasing, operating, and maintaining these advanced imaging devices pose considerable hurdles, particularly for smaller medical facilities and diagnostic laboratories with limited budgets. These financial constraints can restrict access to PET scan technology in resource-limited environments, potentially hindering its availability to patients who would benefit from it. As a result, the steep prices of PET scanners may impede market growth and limit the expansion of various applications of this innovative imaging technology.

Market Trends of the Positron Emission Tomography Market

The Positron Emission Tomography (PET) market is witnessing a transformative shift due to the integration of artificial intelligence (AI) and machine learning technologies. This advancement enhances diagnostic accuracy and efficiency by optimizing image capture, reconstruction, and analysis, leading to improved detection of minor anomalies and precise tumor characterization. Additionally, machine learning tools enable the prediction of patient outcomes and the customization of treatment strategies, further personalizing patient care. As AI and machine learning continue to evolve, their integration into PET systems is set to revolutionize imaging capabilities, making the technology increasingly valuable in clinical and research environments alike.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factor
• Degree of Competition
• Top Investment Pockets
• Ecosystem of the Market
• Value Chain Analysis
• Supply Chain Analysis
• Patent Analysis
• Trade Analysis
• Technology Analysis
• Regulatory Landscape
• Case Study Analysis

Positron Emission Tomography Market, By Product

• Market Overview
• Standalone PET Systems
• PET/CT Systems
  • Low-Slice Scanners
  • Medium-Slice Scanners
  • High-Slice Scanners
• PET/MRI Systems

Positron Emission Tomography Market, By Application

• Market Overview
• Oncology Applications
• Neurological Applications
• Cardiovascular Applications
• Other Applications

Positron Emission Tomography Market, By End User

• Market Overview
• Hospitals And Surgical Centers
• Diagnostic And Imaging Clinics
• Ambulatory Care Centers
• Other End Users

Positron Emission Tomography Market Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2025

Key Company Profiles

• General Electric
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shanghai United Imaging Healthcare Co., Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Canon Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shimadzu Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mediso Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MinFound Medical Systems Co., Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neusoft Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bruker
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CMR Naviscan
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kindsway Biotech
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hermes Medical Solutions
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sofie Biosciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Prescient Medical Imaging
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Reflexion
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cubresa Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Synchropet, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Revvity Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments